Conmed (CNMD) Tops Q1 EPS by 6c, Raises Guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $46.45 -1.25%
EPS Growth %: -7.4%
Financial Fact:
Weighted average common shares Basic: 27.82M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: -7.4%
Financial Fact:
Weighted average common shares Basic: 27.82M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q1 EPS of $0.66, $0.06 better than the analyst estimate of $0.60. Revenue for the quarter came in at $295.5 million versus the consensus estimate of $266.67 million.
GUIDANCE:
Conmed sees FY2023 revenue of $1.21-1.25 billion, versus the consensus of $1.19 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Analysts eye Intuit investor day for signs estimates have troughed
- Faraday Future says it regained Nasdaq compliance after equity shortfall
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
